Campaign for Transformative Therapies logo

CAHC’s Campaign for Transformative Therapies (CTT) believes that encouraging outcomes-based arrangements (OBAs) for gene therapies is necessary to ensure patients can access these innovative cures.

We will work to remove the policy barriers inhibiting VBAs for gene therapies in both public and private markets.

Policy Priorities

The following laws need to be reformed to allow coordination on value-based arrangements:

  • Medicaid Best Price
  • Average Manufacturer Price (AMP)
  • Average Sales Price (ASP)
  • Anti-Kickback Statute


States with Approved Medicaid Pharmacy Outcomes-Based Arrangements

government building background

Join Us

Contact us to learn more about how your organization can join the Campaign and advocate for near-term solutions to help ensure access to gene therapies.

Contact CAHC

Search CAHC